PortfoliosLab logo

bluebird bio, Inc. (BLUE)

Equity · Currency in USD · Last updated Jun 18, 2022

Company Info

ISINUS09609G1004
CUSIP09609G100
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$3.56
Year Range$2.94 - $20.99
EMA (50)$3.87
EMA (200)$8.26
Average Volume$5.51M
Market Capitalization$254.38M

BLUEShare Price Chart


Chart placeholderClick Calculate to get results

BLUEPerformance

The chart shows the growth of $10,000 invested in bluebird bio, Inc. on Jun 20, 2013 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $2,044 for a total return of roughly -79.56%. All prices are adjusted for splits and dividends.


BLUE (bluebird bio, Inc.)
Benchmark (^GSPC)

BLUEReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M-1.66%-10.13%
YTD-64.36%-22.90%
6M-62.01%-21.29%
1Y-83.22%-12.99%
5Y-44.95%8.60%
10Y-16.19%9.47%

BLUEMonthly Returns Heatmap


Chart placeholderClick Calculate to get results

BLUESharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current bluebird bio, Inc. Sharpe ratio is -0.98. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


BLUE (bluebird bio, Inc.)
Benchmark (^GSPC)

BLUEDividend History


bluebird bio, Inc. doesn't pay dividends

BLUEDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


BLUE (bluebird bio, Inc.)
Benchmark (^GSPC)

BLUEWorst Drawdowns

The table below shows the maximum drawdowns of the bluebird bio, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the bluebird bio, Inc. is 98.05%, recorded on May 24, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-98.05%Mar 13, 20181059May 24, 2022
-81.36%Jun 1, 2015241May 12, 2016399Dec 11, 2017640
-49.91%Jul 17, 201389Nov 19, 2013143Jun 17, 2014232
-25.15%Jun 23, 201417Jul 16, 201471Oct 24, 201488
-19.58%Jan 15, 201517Feb 9, 201517Mar 5, 201534
-19.05%Dec 12, 201723Jan 16, 20186Jan 24, 201829
-12.64%Mar 20, 20154Mar 25, 201512Apr 13, 201516
-8.03%Jan 25, 201811Feb 8, 20185Feb 15, 201816
-7.91%Nov 11, 20144Nov 14, 20146Nov 24, 201410
-7.5%Nov 25, 20144Dec 1, 20142Dec 3, 20146

BLUEVolatility Chart

Current bluebird bio, Inc. volatility is 197.58%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


BLUE (bluebird bio, Inc.)
Benchmark (^GSPC)

Portfolios with bluebird bio, Inc.


Loading data...